Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2072590
rs2072590
HAGLR ; HAGLROS
0.720 GeneticVariation GWASDB GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013
dbSNP: rs2072590
rs2072590
HAGLR ; HAGLROS
0.720 GeneticVariation BEFREE To assess the potential implications of microRNAs in ovarian cancer, we investigated the associations between microRNA expression and seven ovarian cancer risk variants discovered from genome-wide association studies (GWAS), namely, rs3814113 on 9p22.2, rs2072590 on 2q31, rs2665390 on 3q25, rs10088218, rs1516982, rs10098821 on 8q24.21 and rs2363956 on 19p13. 22235027

2012
dbSNP: rs2072590
rs2072590
HAGLR ; HAGLROS
0.720 GeneticVariation BEFREE The OC risk-associated SNP rs2072590 lies in non-coding DNA downstream of <i>HOXD3</i> and upstream of <i>HOXD1</i>, and it tags SNPs in the <i>HOXD3</i> 3' UTR. 29262571

2017
dbSNP: rs2072590
rs2072590
HAGLR ; HAGLROS
T 0.720 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. 20852632

2010
dbSNP: rs3814113
rs3814113 		0.720 GeneticVariation BEFREE To assess the potential implications of microRNAs in ovarian cancer, we investigated the associations between microRNA expression and seven ovarian cancer risk variants discovered from genome-wide association studies (GWAS), namely, rs3814113 on 9p22.2, rs2072590 on 2q31, rs2665390 on 3q25, rs10088218, rs1516982, rs10098821 on 8q24.21 and rs2363956 on 19p13. 22235027

2012
dbSNP: rs3814113
rs3814113 		0.720 GeneticVariation BEFREE A genome-wide association study recently identified an association between the rare allele of the single-nucleotide polymorphism (SNP) rs3814113 (ie, the C allele) at 9p22.2 and decreased risk of ovarian cancer for women in the general population. 21169536

2011
dbSNP: rs3814113
rs3814113 		T 0.720 GeneticVariation GWASDB The most significant SNP (rs3814113; P = 2.5 x 10(-17)) was genotyped in a further 2,670 ovarian cancer cases and 4,668 controls, confirming its association (combined data odds ratio (OR) = 0.82, 95% confidence interval (CI) 0.79-0.86, P(trend) = 5.1 x 10(-19)). 19648919

2009
dbSNP: rs3814113
rs3814113 		0.720 GeneticVariation GWASDB GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013
dbSNP: rs10088218
rs10088218
LINC00824
G 0.710 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. 20852632

2010
dbSNP: rs10088218
rs10088218
LINC00824
0.710 GeneticVariation GWASDB GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013
dbSNP: rs10088218
rs10088218
LINC00824
0.710 GeneticVariation BEFREE To assess the potential implications of microRNAs in ovarian cancer, we investigated the associations between microRNA expression and seven ovarian cancer risk variants discovered from genome-wide association studies (GWAS), namely, rs3814113 on 9p22.2, rs2072590 on 2q31, rs2665390 on 3q25, rs10088218, rs1516982, rs10098821 on 8q24.21 and rs2363956 on 19p13. 22235027

2012
dbSNP: rs121913279
rs121913279
PIK3CA
0.710 GeneticVariation BEFREE We also found that an activating (E545K) Pik3ca mutation, unlike Pten inactivation or Pik3ca H1047R mutation, cannot cooperate with Arid1a loss to promote ovarian cancer development in the mouse. 26279473

2016
dbSNP: rs121913279
rs121913279
PIK3CA
0.710 GeneticVariation UNIPROT Mutation of the PIK3CA gene in ovarian and breast cancer. 15520168

2004
dbSNP: rs17879961
rs17879961
CHEK2
0.710 GeneticVariation BEFREE The association between the I157T missense variant was then confirmed in a second sample of Russian patients with borderline ovarian cancers</span> (OR = 2.7; P = 0.06). 16828850

2006
dbSNP: rs17879961
rs17879961
CHEK2
G 0.710 GeneticVariation CLINVAR

dbSNP: rs2363956
rs2363956
ANKLE1
T 0.710 GeneticVariation GWASDB Common variants at 19p13 are associated with susceptibility to ovarian cancer. 20852633

2010
dbSNP: rs2363956
rs2363956
ANKLE1
0.710 GeneticVariation BEFREE To assess the potential implications of microRNAs in ovarian cancer, we investigated the associations between microRNA expression and seven ovarian cancer risk variants discovered from genome-wide association studies (GWAS), namely, rs3814113 on 9p22.2, rs2072590 on 2q31, rs2665390 on 3q25, rs10088218, rs1516982, rs10098821 on 8q24.21 and rs2363956 on 19p13. 22235027

2012
dbSNP: rs2665390
rs2665390
TIPARP ; LOC107986148
0.710 GeneticVariation BEFREE To assess the potential implications of microRNAs in ovarian cancer, we investigated the associations between microRNA expression and seven ovarian cancer risk variants discovered from genome-wide association studies (GWAS), namely, rs3814113 on 9p22.2, rs2072590 on 2q31, rs2665390 on 3q25, rs10088218, rs1516982, rs10098821 on 8q24.21 and rs2363956 on 19p13. 22235027

2012
dbSNP: rs2665390
rs2665390
TIPARP ; LOC107986148
C 0.710 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. 20852632

2010
dbSNP: rs10756819
rs10756819
BNC2
0.700 GeneticVariation GWASDB A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. 19648919

2009
dbSNP: rs10810666
rs10810666 		0.700 GeneticVariation GWASDB A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. 19648919

2009
dbSNP: rs10962656
rs10962656 		0.700 GeneticVariation GWASDB A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. 19648919

2009
dbSNP: rs113954997
rs113954997
RRAS2
0.700 GeneticVariation UNIPROT

dbSNP: rs11782652
rs11782652
CHMP4C
A 0.700 GeneticVariation GWASDB GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013
dbSNP: rs1199923024
rs1199923024
BRIP1
0.700 GeneticVariation UNIPROT